Literature DB >> 7818252

Late-onset mitochondrial myopathy.

W Johnston1, G Karpati, S Carpenter, D Arnold, E A Shoubridge.   

Abstract

In the majority of patients with mitochondrial encephalomyopathies, signs and symptoms appear in the first three decades of life. Here we report on a group of 9 older patients (> 69 years old) with late-onset skeletal myopathy characterized by focal accumulations of deleted mitochondrial DNAs (mtDNAs) and altered muscle energy status, suggestive of a primary mitochondrial disease. The clinical phenotype was somewhat variable. However, all patients shared a common feature of insidious moderate proximal muscle weakness; some also showed fatigability and axial muscle weakness. In situ hybridization analysis demonstrated accumulations of messenger RNAs transcribed from deleted mtDNAs in a relatively large number of muscle fibers in the patient group. These fiber segments appeared as ragged red with the modified Gomori trichrome stain and hyperreactive with a modified succinate dehydrogenase stain. Most were negative for cytochrome c oxidase activity. On transverse sections their mean frequency was 0.69% (trichrome) and 1.97% (succinate dehydrogenase) significantly above control levels. Multiple mtDNA deletions were demonstrated by the polymerase chain reaction in both the patients and an age-matched control group, but not in younger control subjects. Phosphorus 13 magnetic resonance spectroscopy of resting muscle showed a decreased phosphocreatine-inorganic phosphate ratio in the patient group. The myopathy in this group of patients appears to result from mitochondrial dysfunction related to the clonal expansion of different mtDNA deletions in individual fiber segments. While the origin of the mtDNA mutations is not clear, the phenotype seems to represent an exaggerated form of what is observed in the normal aging process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7818252     DOI: 10.1002/ana.410370106

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica.

Authors:  P Chariot; X Chevalier; M Yerroum; I Drogou; F J Authier; R Gherardi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Human mitochondrial DNA with large deletions repopulates organelles faster than full-length genomes under relaxed copy number control.

Authors:  Francisca Diaz; Maria Pilar Bayona-Bafaluy; Michele Rana; Marialejandra Mora; Huiling Hao; Carlos T Moraes
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

3.  Absolute quantitation of a heteroplasmic mitochondrial DNA deletion using a multiplex three-primer real-time PCR assay.

Authors:  Bobby G Poe; Marian Navratil; Edgar A Arriaga
Journal:  Anal Biochem       Date:  2006-12-22       Impact factor: 3.365

Review 4.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

5.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

6.  Functional and structural features of a tandem duplication of the human mtDNA promoter region.

Authors:  H Hao; G Manfredi; C T Moraes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 7.  Mitochondrial encephalomyopathies: what next?

Authors:  S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 8.  Current approach to seronegative myasthenia.

Authors:  Zohar Argov
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

Review 9.  Mitochondrial DNA mutations and aging: devils in the details?

Authors:  Konstantin Khrapko; Jan Vijg
Journal:  Trends Genet       Date:  2008-12-26       Impact factor: 11.639

10.  Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia.

Authors:  Jian-Yong Shao; Hong-Yi Gao; Yu-Hong Li; Yu Zhang; You-Yong Lu; Yi-Xin Zeng
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.